ATC codes:
R03AC02
EMLc
Indication
Asthma
ICD11 code:
CA23
INN
Salbutamol
Medicine type
Chemical agent
List type
Core
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
500 µg per mL in 1 mL ampoule (as sulfate) ;
500 µg per mL in 5 mL ampoule (as sulfate)
Respiratory > Inhalation > solution: 100 µg per actuation in pressurized metered dose inhaler (as sulfate) ; 2.5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers ; 5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers ; 5 mg per mL in multi-dose bottle (as sulfate) for use in nebulizers
Respiratory > Inhalation > solution: 100 µg per actuation in pressurized metered dose inhaler (as sulfate) ; 2.5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers ; 5 mg per 2.5 mL in 2.5 mL ampoule (as sulfate) for use in nebulizers ; 5 mg per mL in multi-dose bottle (as sulfate) for use in nebulizers
EML status history
Sex
All
Age
Also recommended for children
Therapeutic alternatives
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations of essential medicines for children, the Expert Committee recommended the following changes to the listing of salbutamol on the EML and EMLc:
- update the listing description of inhalation delivery systems for consistency across the Model Lists and to better reflect product characteristics.
- amend the listed strength of salbutamol injection from 50 micrograms/mL in 5 mL ampoule to 500 micrograms/mL in 1 mL and 5 mL ampoules.